Our univariate analysis for overall survival showed that older age (≥65 years) (p = 0.02), advanced tumor invasiveness (p < 0.01), nodal metastasis (p = 0.02), distant metastasis (p < 0.01), and low s-FH-Ab levels (p < 0.01) are significant poor prognostic factors (Table 3). This evidence concerns the gene FH and neoplasm.